https://ift.tt/eA8V8J
Eli Lilly said on Tuesday it would buy Prevail Therapeutics in a deal valued at $1.04 billion to expand its presence in the lucrative field of gene therapy.
Tuesday, December 15, 2020
Eli Lilly to buy gene therapy developer Prevail in $1.04 billion deal
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment